A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells

by David H. Quach, Luis Becerra-Dominguez, Rayne H. Rouce, Cliona M. Rooney
Published 2019-07-01